Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma.
Sato Y, Nakano K, Wang X, Fukuda N, Urasaki T, Ohmoto A, Hayashi N, Yunokawa M, Ono M, Tomomatsu J, Saito M, Minami Y, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Takahashi S.
Sato Y, et al. Among authors: minami y.
Cancers (Basel). 2021 Dec 14;13(24):6266. doi: 10.3390/cancers13246266.
Cancers (Basel). 2021.
PMID: 34944888
Free PMC article.